Krystal Biotech, Inc. (KRYS)
290.98
+4.98
(+1.74%)
USD |
NASDAQ |
Jan 22, 15:20
Krystal Biotech Research and Development Expense (TTM): 55.37M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Amicus Therapeutics, Inc. | 142.29M |
| DexCom, Inc. | 590.40M |
| CorMedix, Inc. | 12.46M |
| ADMA Biologics, Inc. | 3.776M |
| Moderna, Inc. | 3.271B |